CareFusion recalls EnVe ventilators

CareFusion has initiated a Class I recall of all EnVe Ventilators manufactured between December 2010 and May 2011, because potential defects could interrupt ventilation to patients.

The issues with the portable ventilators include a potential delay in resuming ventilation after reconnection, potential automatic reset, and potential disconnection during transport. The problems could lead to hypoxia or hypercarbia, which may result in serious neurological injury or death, according to the FDA.

CareFusion is contacting facilities to coordinate hardware and software updates for affected products. Healthcare professionals and patients are encouraged to report any adverse events related to the product to the FDA.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.